ResMed Inc.  

(Public, NYSE:RMD)   Watch this stock  
Find more results for resmed
-0.93 (-1.65%)
Real-time:   11:25AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 55.47 - 56.65
52 week 48.99 - 66.62
Open 56.43
Vol / Avg. 343,338.00/1.11M
Mkt cap 7.76B
P/E 22.71
Div/yield 0.30/2.16
EPS 2.45
Shares 139.99M
Beta 0.66
Inst. own 63%
Apr 26, 2016
Q3 2016 ResMed Inc Earnings Call
Apr 26, 2016
Q3 2016 ResMed Inc Earnings Release
Mar 16, 2016
ResMed Inc at Barclays Global Healthcare Conference
Feb 22, 2016
ResMed Inc to Acquire Brightree´┐Ż Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 19.49% 21.02%
Operating margin 22.98% 24.38%
EBITD margin - 28.73%
Return on average assets 15.15% 15.53%
Return on average equity 22.19% 21.10%
Employees 4,340 -
CDP Score - -


9001 Spectrum Center Blvd
SAN DIEGO, CA 92123-1438
United States - Map
+1-858-7462400 (Phone)
+1-858-8365501 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


ResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.

Officers and directors

Robert D. Douglas President, Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Michael J. Farrell Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Brett A. Sandercock Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Don Darkin President – innovation & operations
Age: 62
Bio & Compensation  - Reuters
Jim Hollingshead Ph.D. President - Americas
Age: 52
Bio & Compensation  - Reuters
Anne Reiser President – Europe & Asia Pacific
Age: 54
Bio & Compensation  - Reuters
David Brian Pendarvis Chief Administrative Officer, Global General Counsel, Company Secretary
Age: 56
Bio & Compensation  - Reuters
Agnes Lee Senior Director - Investor Relations
Bio & Compensation  - Reuters
Peter C. Farrell Ph.D. Non-Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Ronald R. Taylor Lead Independent Director
Age: 67
Bio & Compensation  - Reuters